Letter to the Editor: Unanswered questions about hepatitis B virus infection in patients with COVID‐19
Xiu‐He Lv, Jin‐Lin Yang, Kai Deng – 12 August 2021
YAP‐TEAD mediates PPAR α–induced hepatomegaly and liver regeneration in mice
Shicheng Fan, Yue Gao, Aijuan Qu, Yiming Jiang, Hua Li, Guomin Xie, Xinpeng Yao, Xiao Yang, Shuguang Zhu, Tomoki Yagai, Jianing Tian, Ruimin Wang, Frank J. Gonzalez, Min Huang, Huichang Bi – 12 August 2021
Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition–associated cholestasis in mice
Karim C. El Kasmi, Swati Ghosh, Aimee L. Anderson, Michael W. Devereaux, Natarajan Balasubramaniyan, Angelo D’Alessandro, David J. Orlicky, Frederick J. Suchy, Colin T. Shearn, Ronald J. Sokol – 12 August 2021
Genome‐wide association of individual vulnerability with alcohol‐associated liver disease: A Korean genome and epidemiology study
Kwang Yoon Kim, Jung Oh Kim, Young‐Sang Kim, Ja‐Eun Choi, Jae‐Min Park, Kunhee Han, Da‐Hyun Park, Yon Chul Park, Bom Taeck Kim, Kyung‐Won Hong – 12 August 2021
Pseudo‐Wilsonian Crisis in a ATP7B Heterozygote
Mohammad Qasim Khan, Jerry Yung‐Lun Chin, Hassan Azhari, Charles B. Rosen, Michael D. Leise – 12 August 2021
Recovery and outcomes of patients denied early liver transplantation for severe alcohol‐associated hepatitis
Jessica Musto, Dylan Stanfield, Dana Ley, Michael R. Lucey, Jens Eickhoff, John P. Rice – 12 August 2021
Racial/ethnic disparities in wait‐list outcomes are only partly explained by socioeconomic deprivation among children awaiting liver transplantation
Sharad I. Wadhwani, Jin Ge, Laura Gottlieb, Courtney Lyles, Andrew F. Beck, John Bucuvalas, John Neuhaus, Uma Kotagal, Jennifer C. Lai – 12 August 2021
CAFs shape myeloid‐derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5‐lipoxygenase
Yuli Lin, Qian Cai, Yu Chen, Tiancong Shi, Weiren Liu, Li Mao, Bo Deng, Zhen Ying, Yuan Gao, Haoyang Luo, Xuguang Yang, Xiaowu Huang, Yinghong Shi, Rui He – 12 August 2021
Interferon drives HCV scarring of the epigenome and creates targetable vulnerabilities following viral clearance
Ryan A. Hlady, Xia Zhao, Louis Y. El Khoury, Aesis Luna, Kien Pham, Qunfeng Wu, Jeong‐Heon Lee, Nikolaos T. Pyrsopoulos, Chen Liu, Keith D. Robertson – 12 August 2021
Letter to the Editor: Outcomes in chronic hepatitis B infection and COVID‐19—Not always benign!
Ankur Jindal – 12 August 2021